Therapeutic Innovation

Therapeutic Innovation

Would it surprise you to know that we bring innovation to the field of generic medicine? Or that our research and development group includes more than 2,900 scientists who innovate worldwide every day

It’s true. And it’s why we’ve challenged ourselves to reach higher and go farther for more than 50 years.

The Science of Solutions

Today we design bioequivalent versions of brand name medicines, many of which are difficult-to-manufacture and difficult-to-formulate. We strive to create enhanced versions of medicines to differentiate our products from the pack. And we pursue innovations in oral solid dose medicines, transdermals, injectables, creams, ointments, antiretrovirals and nearly a dozen other critical areas.

Why? Because we believe every disease can have a treatment. We believe every epidemic should come to an end. Medical conditions great and small should be manageable.

  • Antiretrovirals

    These medicines treat HIV/AIDS Often, treatment regimens require a patient to take three or more medicines and may include an antiretroviral (ARV) medicine that breaks down if not refrigerated. Many places hardest hit by the HIV/AIDS epidemic are in warm climates—Africa and India, for instance—where refrigeration can be scarce. For such regions, Mylan was able to make a heat-stable version of an ARV medicine that doesn’t require refrigeration.

  • Cardiovascular

    Our commitment to cardiovascular medicine beats strongly. Using our transdermal technology we have formulated adhesive patches that deliver medicine through the skin

  • Respiratory

    We’re developing asthma and chronic obstructive pulmonary disease (COPD) treatments that use a dry-powder drug-delivery platform technology.

  • Central Nervous System

    Mylan products are the second-most dispensed in the neurologic category in U.S. These are difficult-to-manufacture and difficult-to-formulate products that treat serious diseases. Our innovation in this category has made us a leader in this area.

Always Moving Forward

Innovation is a part of who we are and the reason we see the opportunity in every challenge.
Research and development

Creating Positive Change

We’re committed to setting new standards in health care for people living with HIV/AIDS.
Breaking down barriers

Taking Action

About 34 million people are currently living with HIV/AIDS.
Impact of an epidemic